Probiotik sebagai Pencegahan Diare terkait Antibiotik pada Anak

Marissa Leviani Hadiyanto, Sedyo Wahyudi

Abstract

Hampir setiap antibiotik berpotensi menyebabkan diare, antibiotik spektrum luas yang menargetkan bakteri anaerob memiliki insiden diare terkait antibiotik lebih tinggi. Diare terkait antibiotik muncul ketika antibiotik mengganggu keseimbangan ekologi mikrobiota dalam saluran cerna, dengan mengubah keragaman dan jumlah bakteri di usus. Gambaran klinis diare terkait antibiotik pada anak bervariasi, mulai dari diare ringan encer menyemprot terkadang disertai darah, hingga kolitis hemoragik disertai toksemia. Probiotik telah diusulkan untuk pencegahan diare terkait antibiotik pada anak, di antaranya Lactobacillus sp., Saccharomyces sp., Streptococcus sp., Bifidobacterium sp, dan Bacillus sp.

Every antibiotic has the potential to cause diarrhea, broad-spectrum antibiotics that target anaerobic bacteria have a higher incidence of antibiotic-associated diarrhea. Antibiotic- associated diarrhea occurs when antibiotics disrupt the ecology of the intestinal microbiota by altering the diversity and numbers of bacteria in the gut. The clinical features of pediatric antibiotic-associated diarrhea are variable, ranging from mild self-limited diarrhea through explosive watery diarrhea with occasional blood to severe hemorrhagic colitis and toxemia. Probiotics have been proposed for the prevention of antibiotic-associated diarrhea in children, including Lactobacillus sp., Saccharomyces sp., Streptococcus sp., Bifidobacterium sp., and Bacillus sp.

Full Text:

PDF

References

Lukasik J, Guo Q, Boulus L, Szajewska H, Johnston B. Probiotics for the prevention of antibiotic-associated adverse events in children. PLoS ONE 2020;15(5):1-15.

Guo Q, Goldenberg JZ, Humphrey C, Dib RE, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea (Review). Cochrane Database Systematic Review 2019;4:1-24.

Szajewska H, Canani RB, Guarino A, Hojsak I, Kolacek S, Orel R, et al. Probiotics for the prevention of antibiotic-associated diarrhea in children. ESPGHAN. 2016;62(3):495-6.

Haran JP, Hayward G, Skinner S, Merritt C, Hoaglin DC, Hibberd PL, et al. Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home: Risk of administering IV antibiotics. Am J Emerg Med. 2014;32(10):1195-9.

Mekonnen SA, Merenstein D, Fraser CM, Marco ML. Molecular mechanisms of probiotic prevention of antibiotic-associated diarrhea. Curr Opin Biotechnol. 2020;61:226–34.

Agamennone V, Krul CAM, Rijkers G, Kort R. Practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands. BMC Gastroenterol. 2018;18(103):1-12.

Gupte DS. Antibiotic-associated diarrhoea: An overview. 2017:29-35

Haran JP, Wu G, Bucci V, Fischer A, Keang L, Boyer EW. Antibiotic-associated diarrhoea in emergency department observation unit patients. Cambridge University Press. 2016;144:2176-83.

Nesa NNM, Karyana IPG, Sanjaya Putra IGN. Kejadian antibiotic associated diarrhea yang disebabkan oleh Clostridium difficile dan faktor yang berhubungan. Medicina 2019;50(1):14-9

Kliegman R, Stanton B, Geme III J, Schor N. Nelson textbook of pediatrics. 20th ed. Canada: Elsevier; 2016 .pp. 1240-1

Xu H, Jiang RH, Sheng HB. Meta-analysis of the effects of Bifidobacterium preparations for the prevention and treatment of pediatric antibiotic-associated diarrhea

in China. Elsevier 2017;33:105-13.

Wawan IW. Probiotik sebagai terapi diare akut pada bayi dan anak. OJS Unud. 2016:1-13

Sanz Y, Nadal I, Sanchez E. Probiotics as drugs against human gastrointestinal infections. Recent Patents Anti-Infect Drug Disc. 2007;2(2):148–56.

Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, Vincenzo AD, et al. Probiotics for treatment of acute diarrhoea in children: Randomized clinical trial of five different preparations. BMJ. 2007;335(7615):340.

Pramudianto A, Evaria. MIMS Indonesia petunjuk konsultasi Edisi 16. Jakarta: BIP; 2016

Refbacks

  • There are currently no refbacks.